DJIA 17,812.19 19.51 0.11%
NASDAQ 5,102.81 0.33 0.01%
S&P 500 2,089.14 2.55 0.12%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

61.73 -0.33 (-0.53%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $61.73 -0.53%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $61.70
Previous Close $62.06
Daily Range $60.33 - $62.34
52-Week Range $37.38 - $77.80
Market Cap $7.4B
P/E Ratio 477.38
Dividend (Yield) $0.00 (0.0%)
Volume 732,004
Average Daily Volume 1,908,633
Current FY EPS -$0.64




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

A Pro Forma Profit for ISIS Pharmaceuticals, Inc.

But don't get too excited: The biotech is raking in cash from partners, not by selling drugs.

ISIS Pharmaceuticals (ISIS) Weak On High Volume

Benzinga's Top Initiations

Goldman Sees Bluebird Shares Doubling On 'One-Shot' Gene Therapy

Isis Pharma considers name change after Paris attacks

Alnylam Pharmaceuticals, Inc. Earnings: 100% Positive (Data)

Without any sales, the biotech reiterates its positive pipeline record.

Alnylam Pharmaceuticals Keeping Multiple High-Potential Programs Moving Forward

Pipeline Advancement Provides a Double-Digit Percentage Spark for Isis Pharmaceuticals in October

Isis Pharmaceuticals' pipeline juiced shareholder returns in October.

Isis Posts Narrower-than-Expected Loss in Q3, Shares Up

Aegerion Tops Q3 Earnings, Revenues, PCSK9s Hit Juxtapid

See More ISIS News...

ISIS's Top Competitors

ISIS $61.73 (-0.53%)
Current stock: ISIS
AMGN $162.78 (0.19%)
Current stock: AMGN
GILD $106.57 (0.20%)
Current stock: GILD
BIIB $289.15 (-1.73%)
Current stock: BIIB